Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway

References

• Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, Ros E. The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis. 2011;21(Suppl 2):B32–B48. doi:10.1016/j.numecd.2011.03.009
   PubMed Web of Science ®Google Scholar
• Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. doi:10.2337/diab.37.12.1595
   PubMed Web of Science ®Google Scholar
• Girard J, Lafontan M. Impact of visceral adipose tissue on liver metabolism and insulin resistance. Part II: visceral adipose tissue production and liver metabolism. Diabetes Metab. 2008;34(5):439–445. doi:10.1016/j.diabet.2008.04.002
   PubMed Web of Science ®Google Scholar
• Jaganathan R, Ravindran R, Dhanasekaran S. Emerging role of adipocytokines in type 2 diabetes as mediators of insulin resistance and cardiovascular disease. Can J Diabetes. 2018;42(4):446–456 e441. doi:10.1016/j.jcjd.2017.10.040
   PubMed Web of Science ®Google Scholar
• Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16(2):83–99. doi:10.1038/s41569-018-0097-6
   PubMed Web of Science ®Google Scholar
• Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–28. doi:10.1007/s00125-017-4390-4
   PubMed Web of Science ®Google Scholar
• Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144–153. doi:10.1038/nrendo.2015.216
   PubMed Web of Science ®Google Scholar
• Carpentier AC. Abnormal myocardial dietary fatty acid metabolism and diabetic cardiomyopathy. Can J Cardiol. 2018;34(5):605–614. doi:10.1016/j.cjca.2017.12.029
   PubMed Web of Science ®Google Scholar
• Zorena K, Jachimowicz-Duda O, Slezak D, Robakowska M, Mrugacz M. Adipokines and obesity. Potential link to metabolic disorders and chronic complications. Int J Mol Sci. 2020;21:10. doi:10.3390/ijms21103570
   Web of Science ®Google Scholar
• Zhao S, Kusminski CM, Scherer PE. Adiponectin, leptin and cardiovascular disorders. Circ Res. 2021;128(1):136–149. doi:10.1161/CIRCRESAHA.120.314458
   PubMed Web of Science ®Google Scholar
• Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47–T59. doi:10.1530/JOE-13-0339
   PubMed Web of Science ®Google Scholar
• Zhou P, Xie W, He S, et al. Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis. Cells. 2019;8(3):204. doi:10.3390/cells8030204
   PubMed Web of Science ®Google Scholar
• Lim S, Park J, Um JY. Ginsenoside Rb1 induces beta 3 adrenergic receptor-dependent lipolysis and thermogenesis in 3T3-L1 adipocytes and db/db mice. Front Pharmacol. 2019;10:1154. doi:10.3389/fphar.2019.01154
   PubMed Web of Science ®Google Scholar
• Park SJ, Park M, Sharma A, Kim K, Lee HJ. Black ginseng and ginsenoside Rb1 promote browning by inducing UCP1 expression in 3T3-L1 and primary white adipocytes. Nutrients. 2019;11:11. doi:10.3390/nu11112747
   Web of Science ®Google Scholar
• Jiang L, Yin X, Chen YH, et al. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics. 2021;11(4):1703–1720. doi:10.7150/thno.43895
   PubMed Web of Science ®Google Scholar
• Qin L, Wang J, Zhao R, Zhang X, Mei Y. Ginsenoside-Rb1 improved diabetic cardiomyopathy through regulating calcium signaling by alleviating protein O-GlcNAcylation. J Agric Food Chem. 2019;67(51):14074–14085. doi:10.1021/acs.jafc.9b05706
   PubMed Web of Science ®Google Scholar
• Zhu X, Yang J, Zhu W, et al. Combination of berberine with resveratrol improves the lipid-lowering efficacy. Int J Mol Sci. 2018;19(12):3903. doi:10.3390/ijms19123903
   PubMed Web of Science ®Google Scholar
• Guo R, Wang L, Zeng X, et al. Aquaporin 7 involved in GINSENOSIDE-RB1-mediated anti-obesity via peroxisome proliferator-activated receptor gamma pathway. Nutr Metab. 2020;17:69. doi:10.1186/s12986-020-00490-8
   Google Scholar
• Kusminski CM, Bickel PE, Scherer PE. Targeting adipose tissue in the treatment of obesity-associated diabetes. Nat Rev Drug Discov. 2016;15(9):639–660. doi:10.1038/nrd.2016.75
   PubMed Web of Science ®Google Scholar
• Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–C391. doi:10.1152/ajpcell.00379.2020
   PubMed Web of Science ®Google Scholar
• Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660–671. doi:10.1007/s00125-014-3171-6
   PubMed Web of Science ®Google Scholar
• Lorenzo-Almoros A, Tunon J, Orejas M, Cortes M, Egido J, Lorenzo O. Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol. 2017;16(1):28. doi:10.1186/s12933-017-0506-x
   PubMed Web of Science ®Google Scholar
• Al-Rasheed NM, Al-Rasheed NM, Hasan IH, et al. Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats. Oxid Med Cell Longev. 2017;2017:1092015. doi:10.1155/2017/1092015
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124(8):1160–1162. doi:10.1161/CIRCRESAHA.118.314665
   PubMed Web of Science ®Google Scholar
• Zhou B, Tian R. Mitochondrial dysfunction in pathophysiology of heart failure. J Clin Invest. 2018;128(9):3716–3726. doi:10.1172/JCI120849
   PubMed Web of Science ®Google Scholar
• Zhao XJ, Yu HW, Yang YZ, et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018;18:124–137. doi:10.1016/j.redox.2018.07.002
   PubMed Web of Science ®Google Scholar
• Schultheiss HP, Fairweather D, Caforio ALP, et al. Dilated cardiomyopathy. Nat Rev Dis Primers. 2019;5(1):32. doi:10.1038/s41572-019-0084-1
   PubMed Web of Science ®Google Scholar
• Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461–470. doi:10.1016/j.tips.2015.04.014
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Farrokhi FR, Butler AE, Sahebkar A. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–8161. doi:10.1002/jcp.27603
   PubMed Web of Science ®Google Scholar
• Ravaut G, Legiot A, Bergeron K-F, Mounier C. Monounsaturated fatty acids in obesity-related inflammation. Int J Mol Sci. 2020;22(1):330. doi:10.3390/ijms22010330
   PubMed Web of Science ®Google Scholar
• Marko DM, Foran G, Vlavcheski F, et al. Interleukin-6 treatment results in GLUT4 translocation and AMPK phosphorylation in neuronal SH-SY5Y cells. Cells. 2020;9(5):5. doi:10.3390/cells9051114
   Web of Science ®Google Scholar
• Gao F, Ni Y, Luo Z, et al. Atorvastatin attenuates TNF-alpha-induced increase of glucose oxidation through PGC-1alpha upregulation in cardiomyocytes. J Cardiovasc Pharmacol. 2012;59(6):500–506. doi:10.1097/FJC.0b013e31824c853c
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bauersachs J, Langer HF. Immune mechanisms in heart failure. Eur J Heart Fail. 2017;19(11):1379–1389. doi:10.1002/ejhf.942
   PubMed Web of Science ®Google Scholar
• Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018;8(3):1031–1063.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhu Y, Zhang Y, et al. Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM. Biomed Pharmacother. 2020;127:110081. doi:10.1016/j.biopha.2020.110081
   PubMed Web of Science ®Google Scholar
• Angel Garcia-Merino J, Moreno-Perez D, de Lucas B, et al. Chronic flavanol-rich cocoa powder supplementation reduces body fat mass in endurance athletes by modifying the follistatin/myostatin ratio and leptin levels. Food Funct. 2020;11(4):3441–3450. doi:10.1039/D0FO00246A
   PubMed Web of Science ®Google Scholar
• Nickola MW, Wold LE, Colligan PB, Wang GJ, Samson WK, Ren J. Leptin attenuates cardiac contraction in rat ventricular myocytes. Role of NO. Hypertension. 2000;36(4):501–505. doi:10.1161/01.HYP.36.4.501
   PubMed Web of Science ®Google Scholar
• Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018;39(7):1176–1188. doi:10.1038/aps.2018.40
   PubMed Web of Science ®Google Scholar